Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Marinomed Biotech AG (DE:93Z)
FRANKFURT:93Z
Holding DE:93Z?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 20, 2024 | Simon Nebel Chairman,director | xxxxxxxxxxxxx | €25265 |
| Sep 20, 2024 | Andreas Grassauer Chief Executive Officer | xxxxxxxxxxxxx | €50000 |
| Sep 20, 2024 | Eva Prieschl Grassauer Deputy Chief Executive Officer | xxxxxxxxxxxxx | €50000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Marinomed Biotech AG (DE:93Z)?
Currently, no data Available
What percentage of Marinomed Biotech AG (DE:93Z) stock is held by institutional investors?
Currently, no data Available
What percentage of Marinomed Biotech AG (DE:93Z) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Marinomed Biotech AG (DE:93Z)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.